Evidence map›Paper›PMID 31852860›Full record

ArticleThe Journal of reproduction and development2020

Production of mouse offspring from inactivated spermatozoa using horse PLCζ mRNA.

Yunosuke Yamamoto, Naoki Hirose, Satoshi Kamimura, Sayaka Wakayama, Junya Ito, Masatoshi Ooga, Teruhiko Wakayama

Open access · goldAbstract read
In one paragraph

Article in The Journal of reproduction and development, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Mouse Cloning Using Outbred Oocyte Donors and Nontoxic Reagents.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yunosuke YamamotoFaculty of Life and Environmental Science, University of Yamanashi, Yamanashi 400-8510, Japan.
Naoki HiroseFaculty of Life and Environmental Science, University of Yamanashi, Yamanashi 400-8510, Japan.
Satoshi KamimuraFaculty of Life and Environmental Science, University of Yamanashi, Yamanashi 400-8510, Japan.
Sayaka WakayamaAdvanced Biotechnology Center, University of Yamanashi, Yamanashi 400-8510, Japan.
Junya ItoLaboratory of Animal Reproduction, Graduate School of Veterinary Science, Azabu University, Kanagawa 252-5201, Japan.
Masatoshi OogaFaculty of Life and Environmental Science, University of Yamanashi, Yamanashi 400-8510, Japan.
Teruhiko WakayamaFaculty of Life and Environmental Science, University of Yamanashi, Yamanashi 400-8510, Japan.
University of Yamanashi · JPAzabu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Improving artificial oocyte activation is essential for assisted reproduction or animal biotechnology that can obtain healthy offspring with a high success rate. Here, we examined whether intracytoplasmic injection of equine sperm-specific phospholipase C zeta (ePLCζ) mRNA, the PLCζ with the strongest oocyte activation potential in mammals, could improve the mouse oocyte activation rate and subsequent embryonic development using inactivated spermatozoa. mRNA of mouse PLCζ (mPLCζ) or ePLCζ were injected into mouse oocytes to determine the optimal mRNA concentration to maximize the oocyte activation rate and developmental rate of parthenogenetic embryos in vitro. Full-term development was examined using NaOH-treated inactive spermatozoa using the optimal activation method. We found that the most optimal ePLCζ mRNA concentration was 0.1 ng/µl for mouse oocyte activation, which was ten times stronger than mPLCζ mRNA. The concentration did not affect parthenogenetic embryo development in vitro. Relatively normal blastocysts were obtained with the same developmental rate (52-53% or 48-51%, respectively) when inactive spermatozoa were injected into activated oocytes using ePLCζ or mPLCζ mRNA injection. However, the birth rate after embryo transfer was slightly but significantly decreased in oocytes activated by ePLCζ mRNA (24%) compared to mPLCζ mRNA (37%) or strontium treatment (40%) activation. These results suggest that the higher activation rate does not always correlate the higher birth rate, and some mechanisms might exist in the oocyte activation process that could affect the later developmental stages like full-term development.

Indexed as

AnimalsEmbryonic DevelopmentFemaleHorsesMaleMiceOocytesPhosphoinositide Phospholipase CSpermatozoaSperm Injections, IntracytoplasmicSperm-Ovum InteractionsPhosphoinositide Phospholipase CHorseInactivated spermatozoaMouseOocytes activationSperm-specific phospholipase C zeta (PLCζ)

Identifiers

PMID31852860
PMCPMC7040210
OpenAlexW2995712448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.